stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Transcode Therapeutics IncRNAZ
$1.325.06%-0.0704

Transcode Therapeutics Inc (RNAZ)

Vollbild-Chart

Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)

*Alle Zahlen in Millionen
Enddatum des Zeitraums2026-06-302026-03-312025-12-312025-09-302025-06-30
Periodenlänge3 Monate3 Monate3 Monate3 Monate3 Monate
61.76%6.79
17.7616.034.564.22
Research and Development
27.67%3.69
5.115.483.162.57
Operating Income/Loss
61.76%-6.79
-17.76-16.03-4.56-4.22
Nonoperating Income/Loss
80.29%0.04
0.202.81-0.29-0.06
Income/Loss From Continuing Operations Before Tax
61.55%-6.75
-17.55--4.86-4.28
Income Tax Expense/Benefit, Deferred
99.87%0.00
0.23---
62.05%-6.75
-17.79-13.44-4.86-4.28
Attributable To Parent
62.05%-6.75
-17.79-13.44-4.86-4.28
Available To Common Stockholders, Basic
64.81%-6.87
-19.51-15.05-4.86-4.28
Basic Average Shares
4.39%0.96
0.92-0.830.83
Diluted Average Shares
4.39%0.96
0.92-0.830.83
Basic Earnings Per Share
66.31%-7.17
-21.28--5.82-5.13
Diluted Earnings Per Share
66.31%-7.17
-21.28--5.82-5.13

Ähnlich wie RNAZ